TR200401810T4 - Kısırlık tedavisinde fsh'ın kullanılması - Google Patents

Kısırlık tedavisinde fsh'ın kullanılması

Info

Publication number
TR200401810T4
TR200401810T4 TR2004/01810T TR200401810T TR200401810T4 TR 200401810 T4 TR200401810 T4 TR 200401810T4 TR 2004/01810 T TR2004/01810 T TR 2004/01810T TR 200401810 T TR200401810 T TR 200401810T TR 200401810 T4 TR200401810 T4 TR 200401810T4
Authority
TR
Turkey
Prior art keywords
fsh
infertility treatment
infertility
treatment
dose
Prior art date
Application number
TR2004/01810T
Other languages
English (en)
Inventor
Loumaye Ernest
Duerr-Meyers Louise
Original Assignee
Applied Research Systems Ars Holding N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200401810(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/en
Application filed by Applied Research Systems Ars Holding N. V. filed Critical Applied Research Systems Ars Holding N. V.
Publication of TR200401810T4 publication Critical patent/TR200401810T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

FSH ya da biyolojik aktif analogunun kadinlarda kisirlik (infertilite) tedavilerine yönelik bir ilaç üretiminde kullanilmasi olup, söz konusu ilaç, 100 ila 600 IU araliginda bir baslangiç dozunda ve takibindeki stimulasyon fazinda en az 3 gün için ikinci bir dozda uygulanir.
TR2004/01810T 2000-01-27 2001-01-09 Kısırlık tedavisinde fsh'ın kullanılması TR200401810T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00302840A EP1142582A1 (en) 2000-04-04 2000-04-04 Use of FSH for treating infertility

Publications (1)

Publication Number Publication Date
TR200401810T4 true TR200401810T4 (tr) 2004-09-21

Family

ID=26072975

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01810T TR200401810T4 (tr) 2000-01-27 2001-01-09 Kısırlık tedavisinde fsh'ın kullanılması

Country Status (29)

Country Link
US (1) US7291593B2 (tr)
EP (2) EP1250148B2 (tr)
JP (1) JP5170928B2 (tr)
KR (2) KR100871502B1 (tr)
CN (1) CN1418107A (tr)
AR (1) AR027287A1 (tr)
AT (1) ATE267608T1 (tr)
AU (1) AU783121B2 (tr)
BG (1) BG65915B1 (tr)
BR (1) BR0107881A (tr)
CA (1) CA2397680A1 (tr)
CZ (1) CZ302835B6 (tr)
DE (1) DE60103503T3 (tr)
DK (1) DK1250148T4 (tr)
EA (1) EA004924B1 (tr)
EE (1) EE05444B1 (tr)
ES (1) ES2217113T5 (tr)
HR (1) HRP20020630A2 (tr)
HU (1) HU230833B1 (tr)
IL (2) IL150837A0 (tr)
MX (1) MXPA02007233A (tr)
NO (1) NO324626B1 (tr)
PL (1) PL211113B1 (tr)
PT (1) PT1250148E (tr)
RS (1) RS50805B (tr)
SI (1) SI1250148T2 (tr)
SK (1) SK287717B6 (tr)
TR (1) TR200401810T4 (tr)
WO (1) WO2001054715A1 (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP38708A (en) 2001-09-12 2011-02-10 Merck Serono Sa Use of hcg and lh in controlled ovarian hyperstimulation
IL160780A0 (en) 2001-09-12 2004-08-31 Applied Research Systems USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
WO2008140794A1 (en) * 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
AR081755A1 (es) * 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CA2934579A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
CN111050787A (zh) * 2017-09-01 2020-04-21 辉凌公司 用于受控的卵巢刺激的组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
AU2532101A (en) 2001-08-07
DE60103503T3 (de) 2008-12-24
HUP0204324A3 (en) 2004-12-28
EP1442748A1 (en) 2004-08-04
NO324626B1 (no) 2007-11-26
YU56702A (sh) 2005-09-19
NO20023354L (no) 2002-09-24
AU783121B2 (en) 2005-09-29
BG65915B1 (bg) 2010-05-31
PL356925A1 (en) 2004-07-12
NO20023354D0 (no) 2002-07-11
KR20020081273A (ko) 2002-10-26
CN1418107A (zh) 2003-05-14
SI1250148T2 (sl) 2008-10-31
EP1250148B1 (en) 2004-05-26
EA200200801A1 (ru) 2003-02-27
BG106943A (bg) 2003-02-28
DE60103503T2 (de) 2005-06-09
US20030158106A1 (en) 2003-08-21
ATE267608T1 (de) 2004-06-15
HUP0204324A2 (en) 2003-05-28
KR20070087253A (ko) 2007-08-27
CA2397680A1 (en) 2001-08-02
DK1250148T3 (da) 2004-08-16
RS50805B (sr) 2010-08-31
HU230833B1 (hu) 2018-07-30
JP5170928B2 (ja) 2013-03-27
EE200200415A (et) 2003-12-15
US7291593B2 (en) 2007-11-06
EE05444B1 (et) 2011-08-15
MXPA02007233A (es) 2003-02-12
SI1250148T1 (en) 2004-08-31
PL211113B1 (pl) 2012-04-30
EP1250148B2 (en) 2008-07-02
KR100871499B1 (ko) 2008-12-05
ES2217113T3 (es) 2004-11-01
EA004924B1 (ru) 2004-10-28
JP2003520823A (ja) 2003-07-08
CZ20022555A3 (cs) 2002-11-13
IL150837A0 (en) 2003-02-12
DK1250148T4 (da) 2008-09-22
EP1250148A1 (en) 2002-10-23
SK287717B6 (en) 2011-07-06
HRP20020630A2 (en) 2004-12-31
SK10962002A3 (sk) 2002-12-03
ES2217113T5 (es) 2008-11-01
CZ302835B6 (cs) 2011-11-30
AR027287A1 (es) 2003-03-19
PT1250148E (pt) 2004-09-30
KR100871502B1 (ko) 2008-12-05
WO2001054715A1 (en) 2001-08-02
BR0107881A (pt) 2003-04-01
DE60103503D1 (de) 2004-07-01
IL150837A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
ATE343969T1 (de) Beschichtete medizinische geräte
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE69533112T2 (de) Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE292453T1 (de) Antivirale arznei
HK1068606A1 (en) Novel aminobenzoephenones
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
DE69322251T2 (de) Medizinische zusammensetzung
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
MXPA02006511A (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido.
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
KR900011461A (ko) 트립스타틴을 유효성분으로 하는 치료제
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
UA79424C2 (en) Use of fsh for treatment of infertility in women
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
PT1265629E (pt) Utilizacao da hormona de crescimento em dose baixa